The FDA Meeting of the Psychopharmacologic Drugs Advisory Committee evaluating the New Drug Application for MDMA is happening now. How do clinicians feel about this potential treatment for PTSD?
Rachel Dalthorp, MD, MHSA
Advertisement
Dr Dalthorp is the executive medical director of LifeStance Health and a reproductive psychiatrist at Balance Women’s Health. She is passionate about women's mental health, treatment resistant depression, and innovation in psychiatry.
Articles by Rachel Dalthorp, MD, MHSA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
ADHD Found Connected to Substance Use Disorder, With Sex Prevalence Differences
2
Sleep as Connective Tissue: Quantifying Team Dynamics in Elite Sports
3
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
4
A Moral Injury Update: The PNHP Study and an Imminent Step Toward Peace in the Mideast
5
